Related Experiment Video
Updated: Jun 2, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Molecular pathogenesis of nodular goiter.
1Department for Endocrinology and Nephrology, University of Leipzig, Liebigstrasse 20, D-04103, Leipzig, Germany. Ralf.Paschke@medizin.uni-leipzig.de
Langenbeck'S Archives of Surgery
|April 14, 2011
Summary
Thyroid nodules often result from genetic and environmental factors. Oxidative stress during hormone synthesis, exacerbated by iodine deficiency, causes DNA damage and mutations, leading to nodule formation.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Familial goiters suggest genetic predisposition, but environmental factors also contribute to euthyroid goiter.
- Multifactorial etiology involving genetic and environmental interactions is likely for goiter development.
Purpose of the Study:
- To investigate the underlying mechanisms of thyroid nodule formation, particularly in benign nodules.
- To identify the role of oxidative stress and DNA damage in the pathogenesis of thyroid nodules.
Main Methods:
- Analysis of the progression from thyroid hyperplasia to multinodular goiter.
- Review of known somatic mutations in thyroid carcinomas and hot nodules.
- Investigation of unknown somatic mutations in benign thyroid nodules.
Main Results:
- Thyroid nodule development is triggered by oxidative stress from hormone synthesis, iodine deficiency, or smoking.
- Ineffective antioxidant defense leads to DNA damage and increased mutation rates, promoting tumorogenesis.
- Somatic mutations in benign cold or isocaptant nodules remain largely unknown.
Conclusions:
- Hydrogen peroxide (H2O2) production during thyroid hormone synthesis is a likely cause of frequent thyroid mutagenesis.
- Iodine deficiency increases oxidative burden, DNA damage, and mutagenesis, potentially explaining nodular transformation in endemic goiters.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
